Expectations trend
FY2027 · fiscal year ending 2027-11-30 · fmp
Jefferies (JEF)
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
$48.60-5.02%
Close 2026-11-05 · 1-day change
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.66 → 4.68 EPS · FY ending Nov 30, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for JEF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capital Markets net revenues reach at least $799M by 2026-Q2 | Capital markets revenues also rose 15% to $799M. | Intact | Capital Markets net revenues fall below $698M next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 4 supplied quarters. Management reported: “We continue to expand our M&A business, led by strong sponsor-led activity during the quarter particularly in the healthcare, industrials and energy sectors.” “We continue to make progress in building our corporate M&A business, while staying focused on our historical areas of strength in sponsor-led activity and had very strong performance during the quarter with corporates particularly in the healthcare, industrials and energy sectors.” Revenue was $3.231 billion in 2026-Q3. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-11-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
JEF is a financial company with a cyclical earnings base, meaning results can change with market and industry conditions. Its long-term thesis is intact, with recent performance in the top half of its industry, but earnings quality is fragile and risk is elevated.
JEF is expensive versus peers, and the valuation model shows a negative expectations gap, suggesting expectations are ahead of what the evidence supports. The priced-in assessment is tagged as justified, with low fragility concentration, so the evidence does not point to a valuation cushion against weak execution.
Near term, investment banking and capital markets are showing strength: third-quarter 2026 revenues in both were higher than a year earlier, and management reported record quarterly results in Investment Banking and Equities. Asset Management revenue fell sharply year over year, while recent misses and declining earnings surprises remain risks despite a recent earnings-beat event and a mild favorable signal change.
The multi-year view depends in part on continued growth in Investment Banking and Capital Markets, and on whether the Japan joint venture begins serving clients as planned in January 2027. Near term, a guidance cut or Federal Reserve rate cuts would be unfavorable; continued strong results and higher guidance from sector bellwethers such as Morgan Stanley, Goldman Sachs, and Charles Schwab would support sector momentum.
Over the next one to three years, JEF’s thesis is intact but rests on sustained execution in its stronger businesses and improvement beyond the mixed Asset Management picture. Expensive valuation, fragile earnings quality, and elevated risk keep the evidence balanced. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Investment Banking net revenues grow to at least $1.2B by 2026-Q2 | Jefferies grew investment banking revenues 72% from $700M to $1.21B in 2026-Q2. | Broken | Investment Banking net revenues fall below $700M next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 4 supplied quarters. Management reported: “We continue to expand our M&A business, led by strong sponsor-led activity during the quarter particularly in the healthcare, industrials and energy sectors.” “We continue to make progress in building our corporate M&A business, while staying focused on our historical areas of strength in sponsor-led activity and had very strong performance during the quarter with corporates particularly in the healthcare, industrials and energy sectors.” Revenue was $3.231 billion in 2026-Q3. Delivery assessment Nov 4, 2026 |
Maintain quarterly dividend at $0.40 per share through 2026-Q2 | The company pays a steady $0.40 quarterly dividend and repurchased $372M of shares in H1 2026. | Intact | Dividend per share falls below $0.40 next year | Dividend per share: $0.40 per share FY2026-Q3; GAAP. Published target: $0.40 per share. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 9, 20260.4 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Repurchase shares with at least $250M authorization and active buybacks in 2026 | A supporting condition in Jefferies's published investment case. The stated target is >= $250M authorization and active repurchases. | Intact | Share repurchase authorization falls below $250M or buybacks cease | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.78 → $4.68 · observed estimates
$9.38B → $9.27B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-07-25 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-07-26 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-07-27 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-07-28 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-07-29 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-07-30 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-07-31 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-01 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-02 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-03 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-08-04 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-08-05 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-08-06 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-07 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-08 | $4.54 | $9,208,381,400 | 4 / 6 |
| 2026-08-09 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-10 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-12 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-13 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-14 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-15 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-16 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-17 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-18 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-19 | $4.78 | $9,384,457,676 | 4 / 5 |
| 2026-08-20 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-21 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-22 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-23 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-24 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-25 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-26 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-27 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-28 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-29 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-30 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-08-31 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-01 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-02 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-03 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-04 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-05 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-06 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-07 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-08 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-09 | $4.75 | $9,387,683,076 | 4 / 5 |
| 2026-09-10 | $4.77 | $9,397,164,276 | 4 / 5 |
| 2026-09-11 | $4.77 | $9,397,164,276 | 4 / 5 |
| 2026-09-12 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-13 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-14 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-15 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-16 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-17 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-18 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-19 | $4.64 | $9,393,553,204 | 4 / 5 |
| 2026-09-20 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-21 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-22 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-23 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-24 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-25 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-26 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-27 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-28 | $4.67 | $9,481,973,204 | 4 / 5 |
| 2026-09-29 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-09-30 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-01 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-02 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-03 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-04 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-05 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-06 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-07 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-08 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-09 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-10 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-11 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-12 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-13 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-14 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-15 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-16 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-17 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-18 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-19 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-20 | $4.66 | $9,300,262,660 | 4 / 5 |
| 2026-10-21 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-22 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-23 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-24 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-25 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-26 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-27 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-28 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-29 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-30 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-10-31 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-11-01 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-11-02 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-11-03 | $4.68 | $9,265,964,197 | 4 / 5 |
| 2026-11-04 | $4.68 | $9,265,964,197 | 4 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.